ESR1 and central nervous system cancer: Selective estrogen receptor inhibitors, as well as Selective Estrogen Receptor Modulators, inhibit the growth of gliomas and induce apoptosis [26–29], indicating that estrogen modulates the tumor growth via the classical nuclear estrogen receptors.